Reddys Laboratories Cipla Lupin Zydus Lifesciences Pricing shift: Earlier: 10,00011,000/month (branded) Now: ~3,0005,000/month (generics) In response, Novo Nordisk introduced more affordable branded GLP-1 medications like Extensior and Poviztra
Branded Versus Compounded: Clinical and Practical Distinctions Branded GLP-1 medications (Ozempic, Wegovy, Mounjaro) are manufactured by pharmaceutical companies, undergo rigorous regulatory approval, and include extensive clinical trial data
It functions as a dual GLP-1 and GIP receptor agonist , offering: Enhanced insulin secretion Delayed gastric emptying Appetite suppression Improved glycemic control Tirzepatide demonstrated impressive clinical outcomes in the SURMOUNT and SURPASS trials, with average weight loss of 15-22.5% and substantial A1C reductions
Have a look through our FAQ section or get in touch if youd like to know more about our patented technology or anything we didnt cover.